ACVR2B and hepatocellular carcinoma: Recent studies have identified ACVR2B-AS1 as an OS-independent prognostic factor in digestive system tumors, including gastric and hepatocellular carcinomas, leading to the construction of prognostic models based on this lncRNA [82, 83].